However, there is still no direct evidence about the role of Wnt16 in colorectal carcinogenesis, except that a study indirectly reported that an ellagic acid derivative performed an antitumor action in CRC cells by downregulating the expression of Wnt16 in a dose-dependent manner (66), indicating a potential carcinogenic role of Wnt16 during tumorigenesis. The gene discussed is WNT16; the disease is colorectal carcinoma.